US45168D1046
US45168D1046
IDEXX Laboratories, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 40.86B EUR | 41.52B EUR | 44.52B EUR | 53.93B EUR |
Enterprise Value | 41.32B EUR | 42.42B EUR | 45.43B EUR | 54.72B EUR |
Valuation Multiples | ||||
Trailing P/E | 36.4x | 36.43x | 40.65x | 66.02x |
Forward P/E | 30.95x | -- | -- | -- |
Price to Sales | 8.97x | 9.12x | 10.01x | 16.32x |
Price to Book | 25.34x | 25.75x | 28.61x | 33.59x |
EV/Revenue | 9.08x | 9.32x | 10.22x | 16.56x |
EV/EBITDA | 25.48x | 26.27x | 29.17x | 47.32x |
Price to FCF (P/FCF) | 44.93x | 33.56x | 41.69x | 64.53x |
EV/FCF | 45.44x | 34.29x | 42.53x | 65.49x |
FCF Yield | 2.23% | 2.98% | 2.4% | 1.55% |